학술논문
455O - Efficacy and circulating tumor DNA (ctDNA) analysis of the BRAF inhibitor dabrafenib (D), MEK inhibitor trametinib (T), and anti-EGFR antibody panitumumab (P) in patients (pts) with BRAF V600E–mutated (BRAFm) metastatic colorectal cancer (mCRC)
Document Type
Abstract
Author
Source
In Annals of Oncology 1 October 2016 27 Supplement 6:vi150-vi150
Subject
Language
ISSN
0923-7534